Callum Wilson

2.7k total citations
58 papers, 1.6k citations indexed

About

Callum Wilson is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Callum Wilson has authored 58 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 25 papers in Clinical Biochemistry and 15 papers in Physiology. Recurrent topics in Callum Wilson's work include Metabolism and Genetic Disorders (25 papers), Mitochondrial Function and Pathology (15 papers) and Neonatal Health and Biochemistry (7 papers). Callum Wilson is often cited by papers focused on Metabolism and Genetic Disorders (25 papers), Mitochondrial Function and Pathology (15 papers) and Neonatal Health and Biochemistry (7 papers). Callum Wilson collaborates with scholars based in New Zealand, Australia and United Kingdom. Callum Wilson's co-authors include David R. Thorburn, Peter T. Clayton, Esko Wiltshire, Jane Collins, J V Leonard, Denise M. Kirby, Elena J. Tucker, Candace Guiducci, Stacey B. Gabriel and Alison G. Compton and has published in prestigious journals such as Nature Genetics, SHILAP Revista de lepidopterología and Annals of Neurology.

In The Last Decade

Callum Wilson

56 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Callum Wilson New Zealand 21 956 495 293 241 175 58 1.6k
Jolanta Sykut‐Cegielska Poland 24 998 1.0× 503 1.0× 282 1.0× 336 1.4× 220 1.3× 77 1.7k
Ewa Pronicka Poland 26 1.2k 1.2× 553 1.1× 201 0.7× 326 1.4× 166 0.9× 114 2.0k
Tomáš Honzík Czechia 23 1.1k 1.1× 524 1.1× 233 0.8× 225 0.9× 90 0.5× 102 1.6k
Bruno Maranda Canada 23 714 0.7× 260 0.5× 288 1.0× 394 1.6× 206 1.2× 57 1.4k
Diana Ballhausen Switzerland 19 546 0.6× 356 0.7× 347 1.2× 167 0.7× 126 0.7× 46 1.1k
Carolina Fischinger Moura de Souza Brazil 19 507 0.5× 362 0.7× 427 1.5× 183 0.8× 132 0.8× 110 1.2k
Annette Feigenbaum Canada 28 1.7k 1.8× 1.1k 2.3× 192 0.7× 252 1.0× 94 0.5× 61 2.3k
Shuichi Yatsuga Japan 18 1.5k 1.6× 657 1.3× 442 1.5× 147 0.6× 96 0.5× 50 2.0k
Esther M. Maier Germany 23 974 1.0× 857 1.7× 251 0.9× 353 1.5× 81 0.5× 64 1.7k
Filippo Pinto e Vairo Brazil 20 569 0.6× 235 0.5× 602 2.1× 226 0.9× 207 1.2× 111 1.4k

Countries citing papers authored by Callum Wilson

Since Specialization
Citations

This map shows the geographic impact of Callum Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Callum Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Callum Wilson more than expected).

Fields of papers citing papers by Callum Wilson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Callum Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Callum Wilson. The network helps show where Callum Wilson may publish in the future.

Co-authorship network of co-authors of Callum Wilson

This figure shows the co-authorship network connecting the top 25 collaborators of Callum Wilson. A scholar is included among the top collaborators of Callum Wilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Callum Wilson. Callum Wilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amer, Aya, et al.. (2025). D,L‐3‐hydroxybutyrate in the treatment of glucose transporter 1 deficiency syndrome (Glut1DS). JIMD Reports. 66(1). e12461–e12461.
2.
Wilson, Callum, Howard Potter, Andrea L. Vincent, et al.. (2023). Mitochondrial disease in New Zealand: a nationwide prevalence study. Internal Medicine Journal. 54(3). 388–397. 2 indexed citations
3.
Glamuzina, Emma, et al.. (2022). The risk of classical galactosaemia in newborns with borderline galactose metabolites on newborn screening. JIMD Reports. 64(2). 180–186. 3 indexed citations
4.
Wilson, Callum. (2022). Metabolic disease in the Pacific: Lessons for indigenous populations. Journal of Inherited Metabolic Disease. 45(5). 919–925. 1 indexed citations
5.
Antonarakis, Stylianos E., Aleš Holoubek, J Meylan, et al.. (2021). Dominant monoallelic variant in the PAK2 gene causes Knobloch syndrome type 2. Human Molecular Genetics. 31(1). 1–9. 8 indexed citations
6.
Wilson, Callum, et al.. (2019). The decision to discontinue screening for carnitine uptake disorder in New Zealand. Journal of Inherited Metabolic Disease. 42(1). 86–92. 28 indexed citations
7.
Wilson, Callum, et al.. (2018). The decision to discontinue screening for carnitine uptake disorder in New Zealand. Journal of Inherited Metabolic Disease. 1 indexed citations
8.
Ly, Kien, Callum Wilson, Klaus Lehnert, et al.. (2018). Modelling brain dopamine-serotonin vesicular transport disease in Caenorhabditis elegans. Disease Models & Mechanisms. 11(11). 4 indexed citations
10.
Baertling, Fabian, Laura Sánchez‐Caballero, Mariël A.M. van den Brand, et al.. (2017). NDUFAF4 variants are associated with Leigh syndrome and cause a specific mitochondrial complex I assembly defect. European Journal of Human Genetics. 25(11). 1273–1277. 28 indexed citations
11.
Wilson, Callum, et al.. (2016). The Risk of Fatty Acid Oxidation Disorders and Organic Acidemias in Children with Normal Newborn Screening. JIMD Reports. 35. 53–58. 7 indexed citations
12.
Huppke, Peter, Cornelia Brendel, Vera M. Kalscheuer, et al.. (2012). Mutations in SLC33A1 Cause a Lethal Autosomal-Recessive Disorder with Congenital Cataracts, Hearing Loss, and Low Serum Copper and Ceruloplasmin. The American Journal of Human Genetics. 90(1). 61–68. 68 indexed citations
13.
Huppke, Peter, Cornelia Brendel, Vera M. Kalscheuer, et al.. (2012). Mutations in SLC33A1 Cause a Lethal Autosomal-Recessive Disorder with Congenital Cataracts, Hearing Loss, and Low Serum Copper and Ceruloplasmin. The American Journal of Human Genetics. 90(2). 378–378. 3 indexed citations
14.
Glamuzina, Emma, et al.. (2010). Short Communication Citrullinemia type I: molecular screening of the ASS1 gene by exonic sequencing and targeted mutation analysis. Genetics and Molecular Research. 9(3). 1483–1489. 6 indexed citations
15.
Knaap, Marjo S. van der, Vincent Lai, Wolfgang Köhler, et al.. (2010). Megalencephalic leukoencephalopathy with cysts without MLC1 defect. Annals of Neurology. 67(6). 834–837. 39 indexed citations
16.
Corben, Louise A., Geneieve Tai, Callum Wilson, et al.. (2009). A comparison of three measures of upper limb function in Friedreich ataxia. Journal of Neurology. 257(4). 518–523. 27 indexed citations
17.
Bailey, Lisa, et al.. (2008). Reduced half-life of holocarboxylase synthetase from patients with severe Multiple Carboxylase Deficiency. Human Mutation. 29(6). E47–E57. 18 indexed citations
18.
Siintola, Eija, Meral Topçu, Nina Aula, et al.. (2007). The Novel Neuronal Ceroid Lipofuscinosis Gene MFSD8 Encodes a Putative Lysosomal Transporter. The American Journal of Human Genetics. 81(1). 136–146. 166 indexed citations
19.
Wilson, Callum. (2000). Personal practice: Autosomal recessive osteopetrosis: diagnosis, management, and outcome. Archives of Disease in Childhood. 83(5). 449–452. 84 indexed citations
20.
Wilson, Callum, Cameron Grant, & Clare Wall. (1999). Iron deficiency anaemia and adverse dietary habits in hospitalised children.. PubMed. 112(1089). 203–6. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026